Biohaven Ltd. (BHVN) shares rise premarket as it secures up to $600 million investment from Oberland Capital. Cash reserves ...

Oberland Capital Management is pumping some new life into Biohaven, striking a unique investment deal worth up to $600 ...

Shares of Biohaven (NYSE: BHVN) are surging on Monday. The move comes as the S&P 500 traded mixed and the Nasdaq Composite ...

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the ...

Biohaven will receive up to $600 million to support ongoing clinical trials and the full development of its portfolio.

Biohaven shares rose 8% in premarket trading following an investment in the company by Oberland Capital Management. Shares were trading around $21.43. The stock is down 47% on the year so far.

Currently under review in the U.S. for a rare genetic disorder, the drug is seen by some investors as critical to Biohaven’s ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of Jim Cramer Recently Talked About These 15 Stocks. In this article, we are going to take a ...

EDT Biohaven (BHVN) down 12% to $20.60 after pulling European applicationStay Ahead of the Market: Discover outperforming stocks and ...

We recently published a list of 11 Best Guru Stocks to Buy According to Wall Street Analysts. In this article, we are going ...

EDT Biohaven (BHVN) trading halted, volatility trading pauseStay Ahead of the Market: Discover outperforming stocks and invest smarter ...